Opportunistic bacteria lists on microbiome reports are taxa the lab flags as potentially pathogenic, overgrown, or outside a reference “healthy” band, commonly Escherichia coli, Klebsiella, Enterococcus, Proteus, Pseudomonas, and sometimes Candida or other fungi. The list reflects relative read abundance in that stool sample compared with the vendor’s database, not a culture-proven infection or antimicrobial susceptibility profile.
Stool sequencing under-samples the small intestine and cannot distinguish live pathogens from dead DNA or transient passage. A flagged taxon is a hypothesis for context, not an automatic treatment indication.
What “opportunistic” means on reports
In clinical microbiology, opportunistic pathogens cause disease when host defences fail or barriers break. On consumer panels, the term is operational: the lab marks taxa that appear more often at higher relative abundance in their reference cohort’s “dysbiotic” tail, or taxa with known pathogenic strains in the literature.
Important distinction:
| Clinical microbiology | Consumer report flag |
|---|---|
| Organism isolated from sterile site or toxigenic strain identified | Read count elevated vs other customers |
| Guides antimicrobial choice | No susceptibility data |
| Correlates with symptoms at that site | Stool-colon signal only |
Many flagged taxa are normal colon inhabitants. E. coli and Klebsiella are routinely carried; pathogenicity depends on strain, virulence factors, and host context. A moderate bump after antibiotics or gastroenteritis often reflects ecological vacancy, not an indication for empiric antimicrobials (Palleja et al., 2018).
Common flagged taxa
| Taxon | Why reports flag it | Interpretation limits |
|---|---|---|
| Escherichia coli | Enterobacteriaceae bloom; some pathotypes cause diarrhoea | Most stool E. coli is commensal; sequencing rarely resolves pathotype |
| Klebsiella | Hospital-associated pathogen; Proteobacteria bloom marker | Carriage is common; stool abundance ≠ pneumonia or UTI |
| Enterococcus | Post-antibiotic expansion; VRE concern in hospital settings | Stool signal does not map to infection without clinical correlation |
| Proteus, Pseudomonas | Opportunist labels; dysbiosis rules | Often environmental or transient; method contamination possible |
| Candida (often not bacteria) | Yeast overgrowth narratives | Fungal reads are method-sensitive; not equivalent to oral thrush or systemic candidiasis |
| Proteobacteria (phylum) | “Bloom” when Gram-negative taxa rise collectively | Diet, PPI use, and inflammation associate in cohorts, not individual diagnosis |
Proteobacteria blooms in research often co-occur with reduced diversity and inflammatory states, but the same pattern appears transiently after broad-spectrum antibiotics and in low-fiber diets. Cross-sectional abundance is association, not proof of causation (Shin et al., 2015, see reading list).
A meta-reanalysis of 28 case–control studies (Duvallet et al., 2017) found Proteobacteria enrichment and Enterobacteriaceae/Escherichia/Shigella signals were among the most consistent patterns in diarrhoeal illness, and recurred in IBD patients with diarrhoeal symptoms. Those taxa are also common at low frequency in healthy stool; small relative-abundance swings may reflect faster transit and upper-gut–adapted ecology more than invasive infection. Antibiotic-treated conditions (diarrhoea, IBD) further confound which genera are “disease” vs medication effects.
Lactobacillales and “beneficial” taxa on opportunist lists
Not every flagged taxon is a classic pathogen bloom. In the same meta-analysis, all five Lactobacillales genera that responded non-specifically across multiple diseases were enriched in case patients, despite Lactobacillus often appearing on reports as beneficial. Lactobacillales are adapted to lower pH and the upper gastrointestinal tract; in stool they may rise with diarrhoea, short transit, and redox/pH disruption in the lower gut rather than as proof of probiotic success or specific infection.
| Taxon family | On many reports | Duvallet meta-analysis pattern |
|---|---|---|
| Enterobacteriaceae (E. coli, Klebsiella) | “Opportunistic” | ↑ in diarrhoea; ubiquitous commensals at low level |
| Lactobacillaceae | “Beneficial” | ↑ non-specifically across several diseases, transit/sickness signature |
| Streptococcaceae | Mixed | Common low-abundance stool residents; presence may matter more than small % shifts |
Treat presence/absence of these non-specific genera as more informative than chasing small abundance changes. Full context: Luminal environment, Lactobacillus, Klebsiella and Proteobacteria, Duvallet 2017.
When elevated flags may matter
| Context | Research / clinical pattern | On a report |
|---|---|---|
| Recent broad-spectrum antibiotics | Enterobacteriaceae expansion common | Expected transient shift; compare with Post-antibiotic recovery |
| Acute diarrhoeal illness | Pathogen-specific PCR/stool culture is diagnostic standard | Sequencing may detect carry-over DNA; does not replace stool PCR/culture for Salmonella, Campylobacter, etc. |
| Active IBD flares | Altered composition; calprotectin drives care | Taxa flags are secondary to Calprotectin and endoscopy |
| Immunocompromised host + symptoms | True opportunistic infection risk | Clinical escalation, report alone insufficient |
When no symptoms and no immunocompromise, an isolated opportunistic flag is often low clinical yield. Repeat sampling after diet stabilisation and antibiotic washout carries more weight than a single spike (Retesting over time).
When to escalate clinically
Seek urgent medical care (not supplement adjustment) when:
| Symptom or context | Why sequencing is insufficient |
|---|---|
| Bloody diarrhoea, fever, severe abdominal pain | Red flags, need stool culture, PCR, imaging as indicated |
| Immunocompromised + new GI symptoms | Invasive infection cannot be ruled in/out from 16S alone |
| Persistent diarrhoea after travel or antibiotics | C. difficile and bacterial pathogens need targeted testing |
| Weight loss, nocturnal symptoms, anaemia | Organic disease workup precedes microbiome interpretation |
A normal opportunistic list does not exclude SIBO, coeliac disease, or IBD. Geography of sampling limits what stool can see (SIBO and breath testing).
Database and method limits
Opportunistic calls depend on:
- Reference database completeness, novel or misclassified reads land in generic bins
- 16S resolution, Klebsiella vs Enterobacter vs Citrobacter mis-assignment happens
- Contamination, kit and reagent noise can inflate rare taxa on low-biomass samples
- Relative abundance, one taxon’s rise forces others down mathematically; “high” may be a compositional artefact
Treat species-level clinical claims skeptically when the method is genus-level 16S. Shotgun metagenomics improves resolution but still reports DNA presence, not viability.
What not to conclude from opportunistic lists
| If the report says… | Do not conclude… |
|---|---|
| High Klebsiella | You need herbal antimicrobials or a “gut cleanse” |
| Candida detected | Systemic yeast overgrowth or candidiasis without clinical findings |
| Opportunistic bacteria present | SIBO is proven (breath test is separate) |
| No opportunists flagged | No infection risk or perfect colonization resistance |
| Match to vendor “pathogen list” | Same evidence tier as stool culture at a hospital lab |
Related pages
- Reading your microbiome report, hub for report lines
- Dysbiosis, how imbalance labels are built
- Gut inflammation markers, when calprotectin outranks taxa lists
- Post-antibiotic recovery, expected blooms
- Red flags, when to seek care
- Klebsiella and Proteobacteria, diarrhoea and bloom context
- Lactobacillus, non-specific disease enrichment pattern
- Duvallet 2017, cross-study meta-analysis